Navigation Links
Elsevier Introduces Article-Based Publishing to Increase Publication Speed

Elsevier Introduces Article-Based Publishing to Increase Publication Speed -- AMSTERDAM, October 6, 2010 /PRNewswire-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

Elsevier Introduces Article-Based Publishing to Increase Publication Speed


AMSTERDAM, October 6, 2010 /PRNewswire-FirstCall/ --

- Final and Citable Articles are Published Without Needing to Wait Until a Journal Issue is Complete; Speeding the Publication Process by an Average of 7 Weeks

Elsevier, the world-leading publisher of scientific, technical and medical information products and solutions, announced today the launch of Article-Based Publishing -- a new publishing model that publishes articles as final and citable without needing to wait until a journal issue is complete. With an increasing focus on online publishing, there is a growing need for innovative publication models geared towards individual articles instead of the print-based issue model. Article-Based Publishing is the assigning of final citation data on an article-by-article basis, decoupled from the compilation of the journal issue itself.

"Article-Based Publishing is major step forward in publishing. Now the article is published in its final form within just a few weeks after acceptance, which provides the journal an important competitive advantage," said Professor Rene Janssen, Editor of Organic Electronics. "Authors will be equally pleased to see the results of their research published sooner."

For centuries, academic articles have been published in journals, issue by issue. While this practice has ensured organized citation information, it has also created boundaries for the timing of each published article. Now, Article-Based Publishing makes it possible to publish articles in their final form, with volume, issue and page numbers, before the entire issue is finalised. This new way of publishing speeds up the publication of articles by an average of 7 weeks.

For journals using the Article-Based Publishing model, articles are published in an "Issue in Progress" on SciVerse ScienceDirect ( The traditional volume and issue numbering system will remain as this is the industry standard, and it also provides context to when the complete journal issue was published. Next to the Issue in Progress, a diminishing Article in Press list will still exist for accepted manuscripts and uncorrected proofs only. These articles, although not officially published, are still valuable for fast access to new research results.

"Article-Based Publishing is a key part of Elsevier's efforts to find new ways to speed up and enhance the publication process," said Martin Tanke, Managing Director of S&T Journals for Elsevier. "Along with PeerChoice ( 567) and Article of the Future ( 79), we're continuously addressing our community's requests for publishing innovation."

Elsevier in 2011 also intends to make it possible to have multiple issues in progress at the same time for one journal. This will allow simultaneous publication of special, thematic and regular issues, further reducing article publication times.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet ( and Cell (, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (, SciVerse Scopus (, Reaxys (, MD Consult ( and Nursing Consult (, which enhance the productivity of science and health professionals, and the SciVal suite ( and MEDai's Pinpoint Review (, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Harald Boersma Senior Manager, Corporate Relations, Elsevier +31-20-485-27-36

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
2. Elsevier and the Association of Southeast Asian Institutions
3. Elseviers Partners With QUOSA
4. Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award
5. Elsevier Introduces The American Journal of Medicine Blog
6. Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
7. The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books
8. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
9. Elsevier Launches Ten New eBook Specialty Collections on MD Consult
10. Elsevier Health Sciences Appoints Dr. David Goldmann Editor-in-Chief of its First Consult Point of Care Resource
11. Statement From Michael Hansen, CEO of Elseviers Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells ... 10000 in the Santiago Marriott. The Global Stem Cells Group GMP facility is ... team of qualified medical researchers and practitioners, experienced in administering stem cell protocols ...
(Date:11/30/2015)... GENEVA , December 1, 2015 Partnership ... e for the u niversity ... support treatment s cale - up ... (ARVs)   Africa , where licensees based anywhere ... ARVs based on SDN technology. --> Africa , where licensees ...
(Date:11/30/2015)... , Nov. 30, 2015 Spherix ... company committed to the fostering and monetization of ... current and prospective initiatives designed to create shareholder ... Executive Officer of Spherix. "Based on published reports, ... licensees exceeds $50 billion and Spherix will seek ...
(Date:11/30/2015)... 2015 TapImmune, Inc. (TPIV), ... innovative peptide and gene-based immunotherapeutics and vaccines for the ... will be presenting at the 8 th Annual ... 2.30 PM PT. Dr. John N. Bonfiglio ... giving the presentation and will join TapImmune management in ...
Breaking Biology Technology:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)...  Vigilant Solutions announces today that Mr. Dick ... --> --> Mr. ... partnership at TPG Capital, one of the largest global ... in revenue.  He founded and led TPG,s Operating Group, ... from 1997 to 2013.  In his first role, he ...
Breaking Biology News(10 mins):